Latest Updates

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon

Read more

Pfizer explores options for some rare disease and cancer drugs

Read more

Novavax’s CEO Stanley Erck to retire this month

Read more

Teva says opioids settlement to move forward in US

Read more

Indegene expands European presence with new centre in Germany

Read more

BioAsia 2023 announces speaker line-up

Read more

USFDA approves Prasugrel tablets by Lupin

Read more

USFDA approves Febuxostat tablets by Zydus

Read more

Glenmark Pharma launches Bumetanide injection vials

Read more

Lupin and Exeltis announce reimbursement approval of NaMuscla

Read more